Skip to content

Clinical trials

Observational Myelodysplastic Syndromes trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Observational Country / region: China Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20081
20111
20131
20141
20161
20201
20211
20221
20232
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Completed4
Unknown status4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University People's Hospital3
Bristol-Myers Squibb2
Institute of Hematology & Blood Diseases Hospital, China2
Fujian Medical University1
Gruppo Italiano Malattie EMatologiche dell'Adulto1
Haikou Affiliated Hospital of Central South University Xiangya School of Medicine1
Nanfang Hospital, Southern Medical University1
Qianfoshan Hospital1
The First Affiliated Hospital of Soochow University1
University of Colorado, Denver1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes15
Leukemia, Myeloid, Acute6
Anemia, Aplastic4
Lymphoma4
Multiple Myeloma4
Leukemia3
Anemia, Hemolytic, Autoimmune2
Hemophilia A2
Hemostatic Disorders2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.